November 26, 2020
November 26, 2020

ULTRAOC - To combat the effects of COVID-19!

Get oxygen directly from the comfort of your home! Oxygen therapy has been highlighted as an essential supportive therapy for those with respiratory symptoms of COVID-19.
ULTRAOC - To combat the effects of COVID-19!

We are currently experiencing the greatest pandemic of the century, with more than 50 million cases worldwide. We have all felt the impact of the virus: it has affected the way we live and work, made simple things like going shopping difficult, and created a new reality of social distancing. In these difficult times, we also learn which people and companies we can count on.

During these difficult times, Ultra Controlo and its team of professionals will continue to work to offer the best medical products, reinforcing our commitment to your health and well-being.

‍

To combat the effects of COVID-19!

ULTRAOC is a portable oxygen concentrator that is here to help you! Although supplemental oxygen does not directly treat the virus, it has been highlighted as an essential supportive therapy for those with respiratory symptoms.

As the virus tends to affect the respiratory system, oxygen therapy is used to relieve the patient and reduce recovery time. With the ULTRAOC and all its accessories, you can receive oxygen at home in a comfortable and convenient way. Our concentrator delivers oxygen with a purity of 93% ± 3% and has a service life of more than 18,000 hours, giving you the greatest possible freedom.

‍

With an oxygen flow of up to 10 L/min, it supports patients with respiratory symptoms of SARS-CoV-2. Contact us to check availability.

We are proud to be a healthcare company dedicated to oxygen supply and respiratory well-being.

Get oxygen directly from the comfort of your home! Oxygen therapy has been highlighted as an essential supportive therapy for those with respiratory symptoms of COVID-19.

Resources

Newsletter

Get our news directly
to your mailbox.

Thank you for joining us! 🎉
Oops! Seems like you have a typo.
By clicking the subscribe button, you agree to our Terms and Conditions